DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

TAGRISSO has become a standard treatment due to its strong efficacy in both first-line and adjuvant settings. The growing prevalence of EGFR mutations, a rise in lung cancer diagnoses, and broader ...

DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase ...

Comfort, luxury and off-road capabilities combine in an appealing value proposition. By John Challen. WHAT IS IT? Plug-in ...

THESE motorists have had their cases heard in court recently accused of offences including drink-driving and using a mobile phone at the wheel.

The new MG HS is a huge step forward over the previous model. The petrol engine is a bit underpowered, but the plug-in hybrid ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement ...

Swedish car giant Volvo has moved into the electric saloon space with its new luxury ES90 executive EV. Will it be more ...

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...

DelveInsight's "TEPMETKO Market Size, Forecast, and Market Insight Report" highlights the details around TEPMETKO, a kinase ...

2025申请季战况激烈，春季申请&秋季申请的提前批好消息不断！ 26Spring带奖录取更是直接拿到！